Lung cancer treatment in hours, not weeks: new One-Day radiation trial shows promise
NCT ID NCT06236516
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested a new way to deliver high-dose radiation to small lung tumors in just one day, instead of the usual two to three weeks. Ten patients with early-stage lung cancer or limited lung metastases received a single session of stereotactic body radiotherapy (SBRT) using advanced imaging and adaptive planning, skipping the separate simulation appointment. The goal was to see if this faster, all-in-one approach is feasible and could make treatment more accessible for patients who live far from cancer centers.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- One-fraction stereotactic body radiotherapy (SBRT) using HyperSight and Ethos devices
- What this could lead to
- If successful, this workflow could allow patients with small lung tumors to receive curative radiation in a single day, greatly reducing travel and wait times.
- What could go wrong
- This is a very small feasibility study with only 10 participants. The approach may not work for all tumor types or locations, and technical issues could prevent completion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?